Refika Yigit

5PUBLICATIONS
55CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 05, 2025
Evaluation of BRCA1/2 testing rates in epithelial ovarian cancer patients: lessons learned from real-world clinical data.

Lieke Lanjouw, Claire J H Kramer, Arja Ter Elst

|Jan 24, 2025
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.

Anneke L Eerkens, Martha D Esajas, Koen Brummel

|Nov 23, 2024
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.

Iris A S Stroot, Joost Bart, Harry Hollema

|Sep 03, 2024
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.

Anneke L Eerkens, Koen Brummel, Annegé Vledder

|Jul 21, 2023
The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter.

Laure Nicolai, Refika Yigit, Maaike C G Bleeker

Pageof 1

Frequent Collaborators

5 joint publications

Joost Bart

2 joint publications

Hans W Nijman

2 joint publications

Marian J E Mourits

2 joint publications

Katja N Gaarenstroom